| Literature DB >> 29244756 |
Celine I L Justino1,2, Armando C Duarte3, Teresa A P Rocha-Santos4.
Abstract
The environmental monitoring has been one of the priorities at the European and global scale due to the close relationship between the environmental pollution and the human health/socioeconomic development. In this field, the biosensors have been widely employed as cost-effective, fast, in situ, and real-time analytical techniques. The need of portable, rapid, and smart biosensing devices explains the recent development of biosensors with new transduction materials, obtained from nanotechnology, and for multiplexed pollutant detection, involving multidisciplinary experts. This review article provides an update on recent progress in biosensors for the monitoring of air, water, and soil pollutants in real conditions such as pesticides, potentially toxic elements, and small organic molecules including toxins and endocrine disrupting chemicals.Entities:
Keywords: antibodies; aptamers; biosensors; environmental monitoring; enzymes; pesticides; pollutants
Mesh:
Substances:
Year: 2017 PMID: 29244756 PMCID: PMC5750672 DOI: 10.3390/s17122918
Source DB: PubMed Journal: Sensors (Basel) ISSN: 1424-8220 Impact factor: 3.576
Summary of recent biosensors for environmental monitoring.
| Analyte/Pollutant Detected | Biosensor Type | Recognition Element | Electrode/Sensing Material | Reproducibility | Limit of Detection | Response Range | Recovery (%) | References |
|---|---|---|---|---|---|---|---|---|
| Paraoxon | Electrochemical (amperometric) | Enzyme (AChE 1) | Gold SPE 2 and cysteamine SAM 3 | 5% ( | 2 ppb (*1) | Up to 40 ppb | 97 ± 5% | [ |
| Electrochemical (voltammetric) | Enzyme (butyrylcholinesterase) | SPE 2 with carbon black nanoparticles | 5 µg L−1 (*1) | Up to 30 µg L−1 | 96 ± 2% | [ | ||
| Optical (colorimetric) | Enzyme (AChE 1 and ChO 4) | Iodine-starch | 4.7 ppb (*2) | 10–400 ppb | 88–110% | [ | ||
| Electrochemical (amperometric) | Enzyme (AChE 1) | GCE 5 and gold nanorods | <6% ( | 0.7 nM (*1) | 1 nM–5 µM | 96–98% | [ | |
| Methyl parathion | Electrochemical (impedimetric) | Enzyme (hydrolase) | SPE 2 with Fe3O4 and gold nanoparticles | 7.8% ( | 0.1 ng mL−1 | 0.5–1000 ng mL−1 | [ | |
| Electrochemical (amperometric) | Enzyme (AChE 1) | Graphite and macroalgae | 1.5–1.8 ng mL−1 (*1) | 0–1500 ng mL−1 | [ | |||
| Electrochemical (impedimetric) | Enzyme (AChE 1) | Carbon paste electrode and reticulated spheres structures of NiCo2S4 | 5.3% ( | 0.42 pg mL−1 (*3) | 1.0 pg mL−1–10 ng mL−1 | [ | ||
| Electrochemical | Enzyme (AChE 1) | Carbon paste electrode with chitosan, gold nanoparticles, and Nafion | 5 fg mL−1 | 0.01 pg mL−1–10 ng mL−1 | [ | |||
| Optical | Microplate with silica nanoparticles and PEi 6 hybrid | 0.01 ppm | 0.1–1 ppm | [ | ||||
| Chlorpyrifos | Electrochemical (impedimetric) | Enzyme (tyrosinase) | SPCE 7 and IrOx nanoparticles | <10% ( | 3 nM | 0.01–0.1 µM | 90 ± 9.6% | [ |
| Electrochemical (voltammetric) | Enzyme (AChE 1) | Boron-doped diamond electrode with gold nanoparticles and carbon spheres | 7.3% ( | 0.13 pM (*4) | 0.01 nM–0.1 µM | 82.4–91.2% | [ | |
| Electrochemical (voltammetric) | Aptamers (#1) | Carbon black and GO 8/Fe3O4 | 4.3% ( | 94 pM (*3) | 0.29 nM–0.29 mM | 96–106% | [ | |
| Electrochemical (amperometric) | Enzyme (AChE 1) | GCE 5 with NiO nanoparticles-carboxylic graphene-Nafion | 6.5% ( | 0.05 pM (*2) | 0.1–10 nM | 93.0–105.2% | [ | |
| Dichlorvos | Optical (fluorescence) | Enzyme (AChE 1 and ChO 4) | QD 9 and acetylcholine | 2.2% ( | 4.49 nM (*1) | 4.49–6780 nM | 97.1–100.9% | [ |
| Electrochemical (voltammetric) | Enzyme (AChE 1) | Platinum electrode with ZnO | 12 pM (*1) | 98.5–100.8% | [ | |||
| Electrochemical (impedimetric) | Enzyme (AChE 1) | Ionic liquids-gold nanoparticles porous carbon composite | 6.5% ( | 0.3 pM (*1) | 0.45 pM–4.5 nM | 80.8–93.1% | [ | |
| Acetamiprid | Optical (colorimetric) | Aptamers (#2) | Gold nanoparticles | 5 nM (*3) | 75 nM–7.5 µM | [ | ||
| Electrochemical (impedimetric) | Aptamers (#3) | Gold nanoparticles, MWCNT 10, and rGO 11 nanoribbons | 17 fM (*3) | 50 fM–10 µM | 96.0–106.6% | [ | ||
| Electrochemical (impedimetric) | Aptamers (#3) | Silver nanoparticles and nitrogen-doped GO 8 | 6.9% ( | 33 fM (*3) | 0.1 pM–5 nM | 98.8–106.5% | [ | |
| Electrochemical (impedimetric) | Aptamers (#3) | Platinum nanoparticles | 1 pM | 10 pM–100 nM | 86–109% | [ | ||
| Atrazine | Electrochemical (voltammetric) | Antibodies (monoclonal) | Gold nanoparticles | 2.7–9.2% ( | 0.016 ng mL−1 (*3) | 0.05–0.5 ng mL−1 | 95.5–119.9% | [ |
| Electrochemical (FET 17) | Antibodies (monoclonal) | SWCNT | 1.86 ± 0.26% | 0.01 ng mL−1 | 0.001–10 ng mL−1 | 87.3–108% | [ | |
| Electrochemical (impedimetric) | Aptamers (#4) | Platinum nanoparticles | 2.2 pg mL−1 | 22 pg mL−1–0.22 µg mL−1 | 79–113% | [ | ||
| Electrochemical (amperometric) | Phage/antibody (monoclonal) complex | Magnetic beads functionalized with protein G | 0.2 pg mL−1 | 0.0001–0.001 pg mL−1 | 96–99% | [ | ||
| Pirimicarb | Electrochemical (voltammetric) | Enzyme (laccase) | Carbon paste electrode with MWCNT 10 | 4.6% ( | 43 µg L−1 | 0.24–2.7 mg L−1 | [ | |
| Electrochemical (amperometric) | Enzyme (AChE 1) | Prussian blue-MWCNT 10 SPE 2 | 53.2 ng L−1 (*5) | 1 µg L−1–1 g L−1 | [ | |||
| Carbofuran | Electrochemical (voltammetric) | Enzyme (AChE 1) | IrOx-chitosan nanocomposite | 5.4% ( | 3.6 nM (*2) | 5–90 nM | [ | |
| Electrochemical (amperometric) | Enzyme (AChE 1) | GCE 5 with GO 8 and MWCNT10 | 136 pM | 68–3672 pM | 102.38 ± 2.05% | [ | ||
| Electrochemical (amperometric) | Enzyme (AChE 1) | GCE 5 with NiO nanoparticles-carboxylic graphene-Nafion composite | 6.5% ( | 0.5 pM (*2) | 1 pM–0.1 nM | 93.0–105.2% | [ | |
| Carbaryl | Electrochemical (impedimetric) | Enzyme (AChE 1) | Gold electrode with cysteamine SAM 3 | 32 nM | 1–9 µM | [ | ||
| Electrochemical (impedimetric) | Enzyme (AChE 1) | Interdigitated array microelectrodes with chitosan | 4.8% | 3.87 nM | 4.96–496 nM | [ | ||
| Electrochemical (amperometric) | Enzyme (AChE 1) | MWCNT 10 and GO 8 nanoribbons structure | 7.3% ( | 1.7 nM (*3) | 5–5000 nM | 95.5–96.8% | [ | |
| Electrochemical (amperometric) | Enzyme (AChE 1) | Porous GCE 5 with GO 8 network | 0.74 nM (*3) | 1.49–30.3 nM | 98.3–102.2% | [ | ||
| Optical (SPR 12) | Nucleic acids (#5) | Gold substrate with streptavidin-conjugated QD 9 | 104 CFU mL−1 | 104–108 CFU mL−1 | [ | |||
| Optical (SPR 12) | Antibody (polyclonal) | Gold substrate with protein A SAM 3 | 103 CFU mL−1 | 103–106 CFU mL−1 | [ | |||
| Electrochemical (amperometric) | Antibody (polyclonal) | SPCE 7 with Fe3O4@polydopamine complex | 5.9% ( | 104 CFU mL−1 | 104–108 CFU mL−1 | [ | ||
| Optical (SPR 12) | Antibody (polyclonal) | Gold gratings substrate | 10 CFU mL−1 | [ | ||||
| Optical (SPR 12) | Polymerizable form of histidine | Gold substrate | 3.72 × 105 CFU mL−1 | [ | ||||
| Piezoelectric (QCM 13) | 1.54 × 106 CFU mL−1 | |||||||
| Electrochemical (capacitive) | Polymerizable form of histidine | Gold electrode | 70 CFU mL−1 | 102–107 CFU mL−1 | 81–97% | [ | ||
| Optical (electrochemiluminescence) | Antibodies (polyclonal) | GCE 5 with polydopamine imprinted polymer and nitrogen-doped QD 9 | 8 CFU mL−1 | 10–107 CFU mL−1 | [ | |||
| Electrochemical (amperometric) | Antibodies (polyclonal) | Gold electrode with SWCNT 14 | 102 CFU mL−1 | 102–1010 CFU mL−1 | [ | |||
| Hg2+ | Optical (evanescent-wave optical fibre) | Nucleic acids (#6) | Optical fibre platform | 1.2 nM (*2) | 0–1000 nM | [ | ||
| Optical (fluorescence) | DNA | MOF 15 (UiO-66-NH2) | 17.6 nM | 0.14 µM | [ | |||
| Electrochemical (voltammetric) | Nucleic acids (#7) | Gold substrate with vertically aligned SWCNT | 3.4% | 3 fM (*3) | 10 fM–1 µM | [ | ||
| Optical (SERS 16) | Nucleic acids (#8) | SWCNT 11 and CoFe3O4@Ag substrate | <4% ( | 0.84 pM (*3) | 1 pM–100 nM | 90.50–116.7% | [ | |
| Pb2+ | Optical (fluorescence) | DNAzymes (#9) | Carboxylated magnetic beads | 5 nM (*3) | 0–50 nM | 96.1–101% | [ | |
| Optical (fluorescence) | DNAzyme (#10) | Graphene QD 9 and gold nanoparticles | 16.7 nM | 50 nM–4 µM | [ | |||
| Optical (fluorescence) | Aptamers (#11) | Micro-spin column | <5% ( | 61 nM (*3) | 100–1000 nM | 95.2–109.3% | [ | |
| Brevetoxin-2 | Electrochemical (impedimetric) | Aptamers (#12) | Gold electrodes with cysteamine SAM 3 | 106 pg mL−1 | 0.01–2000 ng mL−1 | 102–110% | [ | |
| Electrochemical (voltammetric) | Cardiomyocyte cells | Microelectrode array with platinum nanoparticles | 1.55 ng mL−1 | 5.6 ng mL−1–1.4 µg mL−1 | [ | |||
| Saxitoxin | Electrochemical (voltammetric) | Cardiomyocyte cells | Microelectrode array with platinum nanoparticles | 0.35 ng mL−1 | 5.6 ng mL−1–1.4 µg mL−1 | [ | ||
| Optical (interferometry) | Aptamers | 0.5 ng mL−1 | 10–2000 ng mL−1 | 101.4–107.3% | [ | |||
| Microcystin | Electrochemical (impedimetric) | Antibodies (monoclonal) | Graphene | 6.9% | 50 pg mL−1 | 0.05–20 ng mL−1 | [ | |
| Electrochemical (voltammetric) | Antibodies (monoclonal) | Gold electrodes with MoS2 and gold nanorods | 5 pg mL−1 (*3) | 0.01–20 ng mL−1 | 98.3–102.1% | [ | ||
| Electrochemical (voltammetric) | Enzyme (protein phosphate 1) | SPE 2 | 0.93 ng mL−1 (*1) | 0.93–40.32 ng mL−1 | [ | |||
| Okadaic acid | Optical (SPR 12) | Antibodies | Gold electrode with carboxymethylated surface | 0.36 ng mL−1 | [ | |||
| Electrochemical (FET 17) | Antibodies (monoclonal) | Graphene | 0.54–2.19% ( | 0.05 ng mL−1 | 0.05–300 ng mL−1 | 98.2–100.7% | [ | |
| Optical (fluorescence) | Antibodies (monoclonal) | Carboxylic acid modified magnetic beads and CdTe QD 9 | 0.05 ng mL−1 | 0.2–20 ng mL−1 | [ | |||
| Domoic acid | Optical (SPR 12) | Antibodies | Gold electrode with carboxymethylated surface | 1.66 ng mL−1 | [ | |||
| Electrochemical (FET 17) | Antibodies (monoclonal) | SWCNT 14 | 0.52–1.43% ( | 10 ng mL−1 | 10–500 ng mL−1 | 92.3–100.3% | [ | |
| Optical (SPR 12) | Antibodies | Glass side chip with gold surface | 0.1 ng mL−1 | 0.1–2 ng mL−1 | [ | |||
| Bisphenol A | Optical (fluorescence) | Aptamers | Gold nanoparticles | 0.1 ng mL−1 | 1–10000 ng mL−1 | [ | ||
| Optical (evanescent-wave optical fibre) | Aptamers (#13) | Optical fibre surface | 0.45 ng mL−1 (*2) | 460 pg mL−1–22.8 ng mL−1 | 91–110% | [ | ||
| Optical (fluorescence) | Aptamers (#14) | Molybdenum carbide nanotubes | 0.23 ng mL−1 | 0–91.3 ng mL−1 | [ | |||
| Nonylphenol | Electrochemical (FET 17) | Antibodies (monoclonal) | SWCNT 14 | 0.56 ± 0.08% ( | 5 ng mL−1 | 5–500 ng mL−1 | 97.8–104.6% | [ |
| 17β-estradiol | Photo-electrochemical | Aptamers (#15) | CdSe nanoparticles and TiO2 nanotubes | 6.33% ( | 33 fM | 0–80 pM | 90.0–102.8% | [ |
| Electrochemical (voltammetric) | Antibodies | Gold electrode with MPA 18 SAM 3 | 2.25 pg mL−1 | 2.25–2250 pg mL−1 | [ | |||
| Electrochemical (capacitive) | Antibodies | Gold electrode with MUA 19 SAM 3 | 1 pg mL−1 (*3) | 1–200 pg mL−1 | 97.96–102% | [ | ||
Notes: 1 AChE: acetylcholinesterase, 2 SPE: screen printed electrode, 3 SAM: self-assembled monolayer, 4 ChO: choline oxidase, 5 GCE: glassy carbon electrode, 6 PEi: polyethyleneimine, 7 SPCE: screen printed carbon electrode, 8 GO: graphene oxide, 9 QD: quantum dots, 10 MWCNT: multi-walled carbon nanotubes, 11 rGO: reduced graphene oxide, 12 SPR: surface plasmon resonance, 13 QCM: quartz crystal microbalance, 14 SWCNT: single-walled carbon nanotubes, 15 MOF: metal organic framework, 16 SERS: surface enhancement Raman spectrum, 17 FET: field effect transistor, 18 MPA: 3-mercaptopropionic acid, 19 MUA: 11-mercaptoundecanoic acid; *1 LOD is calculated at 10% of inhibition of the total enzymatic activity, *2 LOD is 3 s/k with s the standard deviation and k the slope of calibration plot, *3 LOD is three times the signal-to-noise ratio, *4 LOD is calculated at 15% of inhibition of the total enzymatic activity, *5 LOD is calculated at 5% of inhibition of the total enzymatic activity; Oligonucleotides sequences: #1 5′-CCTGCCACGCTCCGCAAGCTTAGGGTTACGCCTGCAGCGATTCTTGATCGCGCTGCTGGTAATCCTTCTTTAAGCTTGGCACCCGCATCGT-3′, #2 5′-CTGACACCATATTATGAAGA-3′, #3 5′-(SH)-(CH2)6-TGTAATTTGTCTGCAGCGGTTCTTGATCGCTGACACCATATTATGAAGA-3′, #4 5′-(SH)-(CH2)6-TACTGTTTGCACTGGCGGATTTAGCCAGTCAGTG-3′; #5 5′-CTCTGTATCGGCCATTGTAGC-3′, #6 5′-NH2-(CH2)6-GTACAAACAA-3′; #7 5′-NH2-(CH2)6-GCTAAGCCATAGATCAATGCGCGGGACTGTCTTT-3′, #8 5′-SH-(CH2)6-TCATGTTTGTTTGTTGGCCCCCCTTCTTTCTTA-3′; #9 5′-TAGTCTACTCTCTGAAGTAGCGCCGCCGTAGTGTAC-3′, #10 5′-/3ThioMC3-D/CGATAACTCACTATrAGGAAGAGATG-3′, #11 5′-GGAGGCTCTCGGGACGACGTCGTCCCGATGCTGCAATCGTAAGAAT-3′, #12 5′-ATACCAGCTTATTCAATTAGATAGTAAGTGCAATCT-3′, #13 5′-Cy5.5-CCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCA-3′, #14 5′-CCGGTGGGTGGTCAGGTGGGATAGCGTTCCGCGTATGGCCCAGCGCATCACGGGTTCGCACCA-3′, #15 5′-GCTTCCAGCTTATTGAATTACACGCAGAGGGTAGCGGCTCTGCGCATTCAATTGCTGCGCGCTGAAGCGCGGAAGC-3′.
Figure 1(A) TEM images of (a) Fe3O4, (b) gold nanoparticles, and (c) Fe3O4@gold nanocomposites; (B) square wave voltammetry measurements of methyl parathion with different concentrations between (a) 0.5 and (j) 1000 ng mL−1; and (C) calibration curves obtained with (a) and without (b) gold nanoparticles (Reproduced from Zhao et al. [8] with permission of The Royal Society of Chemistry).
Figure 2(A) current results of biosensor with and without macroalgae; and (B) total concentration of methyl parathion obtained using the biosensor and SPME-GC/MS over 10 weeks in the same collecting point on a Brazilian lake (Reprinted from Nunes et al. [14], Copyright (2014), with permission from Elsevier).
Figure 3(A) SEM images of NiCo2S4; and (B) differential pulse voltammetry response of the biosensor for concentrations of methyl parathion between 0 and 10 ng mL−1 (Reprinted from Peng et al. [15], Copyright (2017), with permission from Elsevier).
Figure 4Fluorescence emission spectra obtained with the biosensor with the dye (curve a), with the DNAzyme and Pb2+ (curve b), and with the dye, DNAzyme/carboxylated magnetic beads, and Pb2+ (curve c); λex = 490 nm and λem = 530 nm (Reprinted from [52] with kind permission from Springer).
Figure 5(A) working principle of fluorescence immunosensor for the detection of okadaic acid; (B) draw gate for the detection of magnetic beads and measure the fluorescence intensity; and (C) typical fluorescence intensity curves of fluorescent immunosensor under different okadaic acid concentrations. OA: okadaic acid; MBs: magnetic beads; MAb: monoclonal antibodies; QDs-IgG: quantum dots labelled with secondary antibodies IgG (© 2017, Pan et al. [63]. Originally published in “A novel quantum dot fluorescence immunosensor based on magnetic beads and portable flow cytometry for detection of okadaic acid” under Creative Commons 4.0 license).
Figure 6(A) photocurrent change of the aptasensor in different concentrations of 17β-estradiol from 0 (response a) to 80 pM (response n); (B) curve of ΔI corresponding to the concentration of 17β-estradiol from 0 to 80 pM (ΔI was calculated by I0 subtracting I, where I0 and I are the photocurrent before and after incubation of 17β-estradiol). The inset is the linear relationship between ΔI/I0 and the logarithm of 17β-estradiol concentrations from 0.05 to 15 pM; and (C) selectivity of the assay for 17β-estradiol on the aptasensor. The inset are the structural formulas of 17β-estradiol and the tested interferents (Reprinted with permission from Fan et al. [70]. Copyright (2014) American Chemical Society).